DL‑3‑n‑butylphthalide reduces microglial activation in lipopolysaccharide‑induced Parkinson's disease model mice

  • Authors:
    • Yuhua Chen
    • Mujun Jiang
    • Li Li
    • Ming Ye
    • Meiling Yu
    • Lina Zhang
    • Bobo Ge
    • Wenfang Xu
    • Daoxiang Wei
  • View Affiliations

  • Published online on: December 20, 2017     https://doi.org/10.3892/mmr.2017.8332
  • Pages: 3884-3890
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

As microglial activation is a key factor in the pathogenesis of Parkinson's disease (PD), drugs that target this process may help to prevent or delay the development of PD. The present study investigated the effects of dl‑3‑n‑butylphthalide (NBP) on microglia in a lipopolysaccharide (LPS)-induced PD mouse model. The mice were randomly divided into a blank control group, LPS control group and NBP + LPS treatment group. Mice in the treatment group were given an intragastric infusion of 120 mg/kg NBP daily for 30 days during the establishment of the PD mouse model. At 4 and 28 weeks post‑treatment, the motor behaviours of the mice in each group were observed using the rotarod test and the open field test. In addition, immunohistochemical staining was performed to determine the levels of activated microglia, tumour necrosis factor‑α and α‑synuclein, and the number of tyrosine hydroxylase (TH)‑positive cells in the substantia nigra. NBP significantly improved dyskinesia, reduced microglial activation, decreased nuclear α‑synuclein deposition and increased the survival of TH‑positive cells in the substantia nigra of LPS‑induced PD model mice. These findings suggested that NBP may exert its therapeutic effect by reducing microglial activation in a mouse model of PD.
View Figures
View References

Related Articles

Journal Cover

March-2018
Volume 17 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen Y, Jiang M, Li L, Ye M, Yu M, Zhang L, Ge B, Xu W and Wei D: DL‑3‑n‑butylphthalide reduces microglial activation in lipopolysaccharide‑induced Parkinson's disease model mice. Mol Med Rep 17: 3884-3890, 2018
APA
Chen, Y., Jiang, M., Li, L., Ye, M., Yu, M., Zhang, L. ... Wei, D. (2018). DL‑3‑n‑butylphthalide reduces microglial activation in lipopolysaccharide‑induced Parkinson's disease model mice. Molecular Medicine Reports, 17, 3884-3890. https://doi.org/10.3892/mmr.2017.8332
MLA
Chen, Y., Jiang, M., Li, L., Ye, M., Yu, M., Zhang, L., Ge, B., Xu, W., Wei, D."DL‑3‑n‑butylphthalide reduces microglial activation in lipopolysaccharide‑induced Parkinson's disease model mice". Molecular Medicine Reports 17.3 (2018): 3884-3890.
Chicago
Chen, Y., Jiang, M., Li, L., Ye, M., Yu, M., Zhang, L., Ge, B., Xu, W., Wei, D."DL‑3‑n‑butylphthalide reduces microglial activation in lipopolysaccharide‑induced Parkinson's disease model mice". Molecular Medicine Reports 17, no. 3 (2018): 3884-3890. https://doi.org/10.3892/mmr.2017.8332